Allied Blenders cuts ABD Maestro target, delays brand resets, lowers FTA margin view
Two months after saying Maestro would cross ₹100 cr, management now says it will double from ₹40 cr; packaging timelines for OC Blue and B7 pushed back; UK FTA benefit estimate trimmed by a third.
What's new
- Q1 FY27 revenue ₹984 cr, up 5.8% YoY; volume 9m cases, up 6.2%.
- EBITDA ₹120 cr, margin 12.2%; PAT ₹45 cr vs ₹56 cr, hit by ₹24 cr supply chain shock.
- Prestige & above volume grew 10.7%, outpacing mass premium at 2.3%.
- Telangana government dues stand at ₹400 cr; no repayment timeline provided.
Themes from the call
Demand
Premiumisation drives growth: Iconic White targeted at 15m cases in FY27 from 10.5m in Q1, and prestige volumes grew 10.7% vs industry 3.9%.
Margins
Gross margin expanded 277 bps to 46.0%, but supply chain disruption cost ₹24 cr; underlying EBITDA margin was 14.7%.
Capital allocation
Backward integration via Nalgonda malt distillery (H1 FY27) and captive ENA expansion is expected to add ~300 bps margin by FY28, plus 100 bps by FY29.
Guidance watch
- ABD Maestro FY27 revenue guided to double from ₹40 cr (down from earlier 'cross ₹100 cr').
- FY27 EBITDA margin broadly in line with FY26 at ~12-13%; MD reiterated 18% two-year target but with reduced FTA contribution.
- Brand reset packaging: OC Blue in Q3 FY27, B7 in Q4 FY27 (delayed by one quarter each).
- UK FTA margin benefit: 70-80 bps in FY27 (H2), 130-140 bps by FY28 (down from 200 bps).
- MD refused to guide on Maestro long-term profitability or Telangana price hike timing.
Risk flags
- Telangana receivable of ₹400 cr with no repayment schedule; price hike discussions unresolved.
- Supply chain pressure expected to peak in Q2, recovery budgeted for Q3/Q4.
- Reduced Maestro revenue target and delayed brand resets raise execution risk for premium segment.
- FTA benefit estimate trimmed without explanation undermines margin guidance credibility.
Key quotes
-
"I saying as far as ABD Maestro is concerned, we are hoping to cross 100 crores mark soon in terms of annual."
— Allied Blenders MD, May 2026 call -
"We feel that the turnover we clocked in FY26 was a top line of 40 crores, which we will double in FY27."
— Amar Sinha, MD, July 2026 call -
"Our two-year guidance actually remains the same. I would rather want to stand by the mid-teens target; it may go even higher to high teens with an EBITDA margin of 18.0%."
— Amar Sinha, MD, July 2026 call
The brief
Allied Blenders ended its June quarter with decent volume growth but a string of guidance cuts that raise questions about management's credibility. In May, the MD said ABD Maestro would 'cross 100 crores' in annual revenue. Two months later, the company reported FY26 Maestro revenue of just ₹40 crore and guided for it to 'double' in FY27 — an implied target of roughly ₹80 crore. That is a 20% cut, and no explanation was offered. The brand reset timeline for Officer's Choice Blue and Sterling Reserve B7 was also pushed back by a quarter each, and the UK FTA margin benefit estimate was slashed from 200 basis points by FY28 to 130-140 basis points. The MD still stands by the 18% EBITDA margin target, but the path now looks narrower. Q1 underlying results were solid enough — gross margins expanded, prestige volumes outpaced the industry, and cash flow remained strong — but the ₹24 crore supply chain disruption hit profits, and the Telangana government still owes ₹400 crore with no clear repayment date. The stock already knows the bad news: it trades near a 52-week low. But the cumulative downgrades make it harder to underwrite management's long-term margin story. The company's execution on premiumisation and backward integration remains intact, but the credibility gap will need more than a few quarters to repair.
Allied Blenders is delivering on volume but cutting guidance faster than it can explain. Credibility is the new risk.